Harvard Bioscience Inc (HBIO)
3.44
-0.01
(-0.29%)
USD |
NASDAQ |
May 16, 16:00
3.44
0.00 (0.00%)
After-Hours: 20:00
Harvard Bioscience Revenue (Annual): 112.25M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 112.25M |
| December 31, 2022 | 113.34M |
| December 31, 2021 | 118.90M |
| December 31, 2020 | 102.10M |
| December 31, 2019 | 116.18M |
| December 31, 2018 | 120.77M |
| December 31, 2017 | 77.41M |
| December 31, 2016 | 104.52M |
| December 31, 2015 | 108.66M |
| December 31, 2014 | 108.66M |
| December 31, 2013 | 105.17M |
| December 31, 2012 | 111.17M |
| December 31, 2011 | 108.86M |
| Date | Value |
|---|---|
| December 31, 2010 | 108.18M |
| December 31, 2009 | 85.77M |
| December 31, 2008 | 88.05M |
| December 31, 2007 | 83.41M |
| December 31, 2006 | 76.18M |
| December 31, 2005 | 67.43M |
| December 31, 2004 | 64.74M |
| December 31, 2003 | 87.14M |
| December 31, 2002 | 57.38M |
| December 31, 2001 | 40.87M |
| December 31, 2000 | 30.57M |
| December 31, 1999 | 26.18M |
| December 31, 1998 | 12.15M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
102.10M
Minimum
2020
118.90M
Maximum
2021
112.55M
Average
113.34M
Median
2022
Revenue (Annual) Benchmarks
| Bruker Corp | 2.964B |
| Azenta Inc | 665.07M |
| Bionano Genomics Inc | 36.12M |
| Akoya Biosciences Inc | 96.63M |
| Singular Genomics Systems Inc | 2.911M |